Baker Ellis Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.38M Buy
13,294
+629
+5% +$147K 0.35% 66
2026
Q1
$3.1M Buy
12,665
+190
+2% +$44.3K 0.37% 69
2025
Q4
$2.58M Buy
12,475
+600
+5% +$119K 0.31% 73
2025
Q3
$2.2M Buy
11,875
+3,096
+35% +$530K 0.27% 77
2025
Q2
$1.34M Hold
8,779
0.18% 92
2025
Q1
$1.46M Buy
8,779
+1,368
+18% +$214K 0.21% 89
2024
Q4
$1.07M Sell
7,411
-296
-4% -$45.9K 0.16% 96
2024
Q3
$1.25M Sell
7,707
-120
-2% -$19.1K 0.18% 96
2024
Q2
$1.14M Sell
7,827
-50
-0.6% -$7.44K 0.17% 99
2024
Q1
$1.25M Sell
7,877
-7,013
-47% -$1.12M 0.19% 99
2023
Q4
$2.33M Sell
14,890
-220
-1% -$33.7K 0.37% 72
2023
Q3
$2.35M Sell
15,110
-2,200
-13% -$363K 0.42% 60
2023
Q2
$2.87M Sell
17,310
-330
-2% -$53.3K 0.49% 59
2023
Q1
$2.73M Sell
17,640
-26,281
-60% -$4.24M 0.49% 60
2022
Q4
$7.76M Sell
43,921
-865
-2% -$149K 1.5% 16
2022
Q3
$7.32M Buy
44,786
+6,798
+18% +$1.15M 1.59% 15
2022
Q2
$6.74M Buy
37,988
+31
+0.1% +$5.52K 1.4% 18
2022
Q1
$6.73M Buy
37,957
+1,411
+4% +$240K 1.2% 22
2021
Q4
$6.25M Buy
36,546
+777
+2% +$127K 1.1% 24
2021
Q3
$5.64M Buy
35,769
+446
+1% +$76.1K 1.09% 25
2021
Q2
$5.82M Sell
35,323
-3,387
-9% -$561K 1.14% 22
2021
Q1
$6.36M Buy
38,710
+4,058
+12% +$657K 1.37% 14
2020
Q4
$5.45M Sell
34,652
-930
-3% -$137K 1.3% 19
2020
Q3
$5.3M Buy
35,582
+757
+2% +$112K 1.48% 11
2020
Q2
$4.9M Buy
34,825
+323
+0.9% +$47.1K 1.44% 12
2020
Q1
$4.52M Buy
34,502
+2,560
+8% +$363K 1.62% 13
2019
Q4
$4.66M Buy
31,942
+525
+2% +$71.2K 1.29% 19
2019
Q3
$4.07M Buy
31,417
+210
+0.7% +$27.7K 1.08% 23
2019
Q2
$4.35M Sell
31,207
-270
-0.9% -$37.4K 1.15% 20
2019
Q1
$4.4M Buy
31,477
+960
+3% +$129K 1.23% 17
2018
Q4
$3.94M Sell
30,517
-921
-3% -$128K 1.19% 18
2018
Q3
$4.34M Sell
31,438
-183
-0.6% -$24.3K 1.12% 20
2018
Q2
$3.84M Sell
31,621
-765
-2% -$95.4K 1.01% 25
2018
Q1
$4.15M Sell
32,386
-120
-0.4% -$16.2K 1.09% 21
2017
Q4
$4.54M Sell
32,506
-735
-2% -$102K 1.14% 19
2017
Q3
$4.32M Buy
33,241
+50
+0.2% +$6.63K 1.15% 18
2017
Q2
$4.39M Buy
33,191
+143
+0.4% +$18.2K 1.2% 19
2017
Q1
$4.12M Buy
33,048
+71
+0.2% +$8.48K 1.18% 18
2016
Q4
$3.8M Sell
32,977
-36
-0.1% -$4.16K 1.11% 20
2016
Q3
$3.9M Sell
33,013
-863
-3% -$105K 1.18% 19
2016
Q2
$4.11M Buy
33,876
+221
+0.7% +$25.1K 1.29% 16
2016
Q1
$3.64M Buy
33,655
+340
+1% +$35.2K 1.2% 19
2015
Q4
$3.42M Buy
33,315
+17
+0.1% +$1.71K 1.17% 20
2015
Q3
$3.11M Buy
33,298
+956
+3% +$92.5K 1.11% 19
2015
Q2
$3.15M Sell
32,342
-1,306
-4% -$131K 1.06% 22
2015
Q1
$3.38M Buy
33,648
+3,175
+10% +$323K 1.08% 21
2014
Q4
$3.19M Sell
30,473
-1,908
-6% -$201K 1.07% 20
2014
Q3
$3.45M Buy
32,381
+3,900
+14% +$404K 1.19% 19
2014
Q2
$2.98M Sell
28,481
-912
-3% -$92.2K 1.01% 22
2014
Q1
$2.89M Buy
29,393
+1,350
+5% +$125K 1% 24
2013
Q4
$2.57M Buy
28,043
+1,190
+4% +$110K 0.89% 27
2013
Q3
$2.33M Buy
26,853
+990
+4% +$88.8K 0.88% 28
2013
Q2
$2.22M Buy
+25,863
New +$2.19M 0.88% 27

Other funds holding JNJ

Baker Ellis Asset Management's JNJ Position: Q2 2026 in Review

Baker Ellis Asset Management increased its Johnson & Johnson (JNJ) stake by 5% in Q2 2026, buying an estimated $147K and bringing the position to 13,294 shares worth $3.38M. The position accounts for 0.35% of the portfolio, ranked #66.

Baker Ellis Asset Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.76M in Q4 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Baker Ellis Asset Management held 13,294 shares of Johnson & Johnson worth $3.38M as of Q2 2026.
  • Baker Ellis Asset Management bought 629 Johnson & Johnson shares in Q2 2026, an estimated $147K.
  • Johnson & Johnson made up 0.35% of Baker Ellis Asset Management's portfolio in Q2 2026, its #66 holding.
  • Baker Ellis Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Baker Ellis Asset Management's Johnson & Johnson position peaked at $7.76M in Q4 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.